<DOC>
	<DOCNO>NCT00964366</DOCNO>
	<brief_summary>This randomize , half-face study . On 1 side face , subject apply 1 2 test product , clindamycin benzoyl peroxide dapsone gel contra lateral side face remain non-treated serve control .</brief_summary>
	<brief_title>Study Determine Compare Tolerance Irritation Potential Topical Acne Medications</brief_title>
	<detailed_description>This single-blind ( blind expert grader ) , parallel group , randomize , half-face study conduct one clinical site . On 1 side face , subject apply 1 2 test product , clindamycin benzoyl peroxide dapsone gel contra lateral side face remain non-treated serve control . Approximately 25-30 male female healthy subject without facial acne , age 18 45 , randomly assign product . The eligible subject qualify entered 2-week treatment phase . The first application study medication supervise site , Monday Friday week . Any additional application applied subject home evening time application record diary card . Subjects apply study product home Saturdays Sundays record time application diary card . A blinded expert grader rate comparative product tolerance study study product apply . Instrumentation measurement TEWL utilized evaluate product mildness . Duplicate sebum sample take left right forehead area assess . Subject complete questionnaire adverse event record .</detailed_description>
	<mesh_term>Acne Vulgaris</mesh_term>
	<mesh_term>Clindamycin</mesh_term>
	<mesh_term>Clindamycin palmitate</mesh_term>
	<mesh_term>Clindamycin phosphate</mesh_term>
	<mesh_term>Dapsone</mesh_term>
	<mesh_term>Benzoyl Peroxide</mesh_term>
	<criteria>Capable understand willing provide sign dated write voluntary inform consent ( local national authorization requirement ) protocol specific procedure perform . Male female subject age 18 45 year time consent . Has Fitzpatrick Skin Type I , II , III . Is willing discontinue use facial product ( cleanser provide makeup razor facial shave product ) face 3 day baseline/day 0 visit use provide facial product normal makeup razor facial shave product duration study . Is willing change brand makeup razor facial shave product study . Is willing refrain use facial product face study product normal makeup razor facial shave product duration study . Is willing refrain exercise prior instrument appointment . Is willing refrain shower drinking caffeinated beverage within 1 hour prior instrument visit . Is willing report site visit clean face makeup . Is willing avoid sunburn , tan , tan bed excessive sun exposure . Understands skin tone change significantly study necessary discontinue participation . Able complete study comply study instruction . Sexually active female childbearing potential participating study must agree use medically acceptable method contraception receive protocolassigned product . A woman childbearing potential define one biologically capable become pregnant ; include perimenopausal woman le 2 year last menses . Female subject pregnant , try become pregnant , breast feeding . Male subject facial beard ( mustache and/or goatee acceptable ) . Is Type I diabetic . Has active chronic skin allergy . Has history acute chronic disease might interfere , increase risk study participation . Has participate facial study precede 30 day clinical study precede 14 day . Had skin cancer treatment precede 12 month . Has damage skin facial area ( eg , sunburn , tattoo , scar ) . Had medical procedure ( e.g. , laser resurfacing , chemical peel , plastic surgery ) facial area precede 12 month . Had cosmetic procedure ( e.g. , microdermabrasion , etc . ) facial area within 8 week baseline visit . Use topical retinoids related agent treatment acne photoaging precede 6 month . Live household currently enrol subject . Employees investigator/clinical research organization ( CRO ) Stiefel Laboratories involve study , immediate family member ( partner , offspring , parent , sibling sibling 's offspring ) employee involve study . Any condition factor investigator duly assign representative believe may affect skin response interpretation test result .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>45 Years</maximum_age>
	<verification_date>March 2012</verification_date>
</DOC>